Takeda Pharmaceutical Co. Ltd.
Financial
Business Segments
| Segments | 2022 ($ Millions) |
|---|---|
| Gastroenterology (GI) | *** |
| Rare Diseases | *** |
| PDT immunology | *** |
| Oncology | *** |
| Neuroscience | *** |
| Others | *** |
Business Segments Chart
Business Regions
| Regions | 2022 ($ Millions) |
|---|---|
| U.S. | *** |
| Japan | *** |
| Europe & Canada | *** |
| Growth & Emerging Markets | *** |
Business Regions Chart
This information is available for BCC Research members only.
